What is Dimension Inx?
Dimension Inx is at the forefront of biofabrication, developing a novel 3D-Painting Materials Design and Manufacturing System. This technology is engineered to provide the versatility, manufacturability, and affordability required for the widespread adoption of regenerative medical products. By fundamentally changing how human diseases and debilitations are treated, Dimension Inx aims to revolutionize patient care. The company's expertise spans materials science and tissue engineering, positioning it to collaborate with leading clinicians, surgeons, and medical product companies to bring new medical solutions to market.
How much funding has Dimension Inx raised?
Dimension Inx has raised a total of $15.2M across 3 funding rounds:
Unspecified
$35K
Angel/Seed
$3.2M
Series A
$12M
Unspecified (2019): $35K, investors not publicly disclosed
Angel/Seed (2020): $3.2M led by KdT Ventures,, Better Ventures, and Rise of the Rest Seed Fund
Series A (2023): $12M supported by KdT Ventures and Prime Movers Lab
Key Investors in Dimension Inx
KdT Ventures
KdT Ventures is a venture capital firm specializing in early-stage frontier science investing, focusing on transformative technologies in medicine, chemicals, and materials. They often provide the first institutional check into companies, leading or co-leading pre-seed and seed funding rounds.
Prime Movers Lab
Prime Movers Lab is a venture capital firm that focuses on funding breakthrough scientific startups aimed at transforming industries and improving lives. They seek to support founders with innovative ideas and a growth mentality, helping them realize their ambitious plans.
Better Ventures
Better Ventures is a mission-driven venture capital firm that invests in early-stage startups focusing on leveraging science and technology to create a sustainable economy that benefits people and the planet. Their investment themes include sustainable industry, improving human health, and equipping tomorrow's workforce.
What's next for Dimension Inx?
The recent major enterprise-level funding and strategic investment signal a pivotal growth phase for Dimension Inx. This capital infusion is expected to accelerate the company's research and development efforts, scale its manufacturing capabilities, and expand its market reach. The company's focus on biofabrication and regenerative medicine places it in a high-growth sector, with potential for significant impact on patient outcomes and the healthcare industry. Future developments will likely involve further clinical validation, strategic partnerships, and the commercialization of its innovative 3D-painting system.
See full Dimension Inx company page
